A total of seventeen @entity1 with @entity157 ( @entity157 ), nineteen HCCs, who underwent as an initial treatment transcatheter hepatic segmental or subsegmental arterial administration of SMANCS alone for @entity157 ( @entity157 ), were studied to evaluate the efficacy and complication of that treatment. The initial treatments provided CR in eight @entity1 (47%), and repeat administrations of SMANCS achieved CR in an additional four @entity1 (24%). The initial treatment provided a dense deposit of @entity4831 in the twelve @entity5 (63%), in five of which @entity4831 was thereafter washed out in some portions of the @entity5 . Complete @entity39 was obtained in nine (75%) of fourteen hypervascular @entity5 , and in two (40%) of five intermediately vascular or @entity5 . Segmental or subsegmental administration of SMANCS was well tolerated with self-controlled abdominal @entity158 well responding to medication. Ascites was seen in three cases, and @entity194 of the segment infused occurred in five @entity1 . Cholinesterase significantly reduced at one week and one month, then recovered to baseline two to three months after initial treatment. The cumulative survival rates were 77% at 1 year, 66% at 2 years, and 53% at 5 years in the whole @entity1 . The survival rate was 100% at 5 years in the @entity1 A group. In the @entity1 who obtained CR using SMANCS alone, the survival rates were 89% at 1 year, 74% at 2 years and 56% at 5 years. Although this method may transiently deteriorate hepatic function, segmental or subsegmental administration of SMANCS may be an excellent therapeutic method for treatment of @entity157 and promising for use in properly selected @entity1 .

[Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of XXXX ].

@entity1 :: ('9606', 'Species') :: ['Child', 'patients'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrosis'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'hypovascular tumors', 'tumors'] @entity4831 :: ('MESH:D004998', 'Chemical') :: ['Lipiodol'] @entity194 :: ('MESH:D001284', 'Disease') :: ['atrophy'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain or fever'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'hepatocellular carcinoma']
@entity157 :: (MESH:D006528,Disease) :: ['hepatocellular carcinoma']
